Law and statutory body

Drugs and Cosmetics Act, 1940 (Section 26A) and FDC restrictions

GS2 HealthGS3 Science and TechnologyPrelims and Mains

In the news since 22 August 2026

Why in news
On 22 August 2026, the Health Ministry announced restrictions on all Fixed Dose Combinations of Chlorpheniramine Maleate and Phenylephrine Hydrochloride, with a warning against use in children below four years.
What it is
The Drugs and Cosmetics Act, 1940 regulates the import, manufacture, sale and distribution of drugs and cosmetics in India. Section 26A lets the Central Government prohibit or restrict a drug in the public interest. A Fixed Dose Combination (FDC) puts two or more active drug ingredients in one fixed ratio in a single dosage form.
Legal provision used
The notification was issued under Section 26A of the Drugs and Cosmetics Act, 1940, in the interest of public health.
Advisory process
The decision followed recommendations of an Expert Committee and the Drugs Technical Advisory Board (DTAB).
Labelling requirement
The warning must appear on the label, package insert and promotional literature.
DTAB
DTAB is the statutory technical body under the Drugs and Cosmetics Act that advises the Central and State Governments on technical matters.

Don’t confuse with DTAB vs DCC: DTAB advises on technical matters; the Drugs Consultative Committee (DCC) promotes uniform administration of the Act across States.

Laws, judgments and statutory bodies: 30 Prelims questions since 2013 (what the law says, who chairs, legal basis). In Mains, 44 news-triggered questions, most in GS2, asking for provisions and challenges.

Test yourself

Worth revising until Prelims 2028: most news questions come within two years of the event.

Each time it was in the news

  1. 22 August 2026

    On 22 August 2026, the Health Ministry announced restrictions on all Fixed Dose Combinations of Chlorpheniramine Maleate and Phenylephrine Hydrochloride, with a warning against use in children below four years.